Gradient Medical, founded in 2020 and headquartered in Raleigh, North Carolina, is dedicated to revolutionizing oncology treatment through its innovative ACE therapy. The company specializes in developing minimally invasive interventional oncology services that utilize nanosecond pulsed electric fields to target and disrupt cancer cells. By providing real-time sensing and control, Gradient Medical aims to maximize therapeutic effectiveness and improve outcomes for patients with primary and metastatic tumors.
Since its inception, Gradient Medical has made significant strides in the field of targeted cancer therapy. Its breakthrough technology has garnered attention for its potential to transform cancer treatment, offering a promising alternative to traditional methods. The company's commitment to innovation and excellence positions it as a leader in the oncology sector, with a growing impact on patient care and clinical practices.
